NCT02129777 Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02070965 DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02045277 Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02016482 A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis Status COMPLETED Phase PHASE3
NCT01989429 Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients Status COMPLETED Phase PHASE3
NCT01987843 Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01938599 Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01899729 A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01893567 Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% Status COMPLETED Phase PHASE4
NCT01882647 A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) Status COMPLETED Phase PHASE3
NCT01875991 Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept Status COMPLETED Phase PHASE4
NCT01871402 A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) Status COMPLETED Phase PHASE3
NCT01815723 Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis Status WITHDRAWN Phase PHASE3
NCT01777191 Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01766440 PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT01729754 A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) Status COMPLETED Phase PHASE3